ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Vasculitis"

  • Abstract Number: 2421 • ACR Convergence 2023

    Optic Nerve Sheath Measurement on Ultrasound: A Novel Diagnostic Test for Giant Cell Arteritis

    Hussein Baalbaki1, David Dube1, Carolyn Ross2, Stephanie Ducharme-Benard3, Samer Hussein4, Rosalie-Selene Meunier4, Christian Pagnoux5 and Jean-Paul Makhzoum2, 1Hopital du Sacre-Coeur de Montreal, University of Montreal, Montreal, QC, Canada, 2Vasculitis Clinic, Canadian Network for Research on Vasculitides, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada, 3Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada, 4Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada, 5Mount Sinai Hospital, Toronto, ON, Canada

    Background/Purpose: Confirming the diagnosis of giant cell arteritis (GCA) remains challenging. Available diagnostic tests have limited accuracy and availability. Recently, optic nerve sheath enhancement on…
  • Abstract Number: 0479 • ACR Convergence 2023

    Exploring Reproductive Experiences with Women Enrolled in the Vasculitis Pregnancy Registry

    Catherine Sims1, Christine Yeung2, Heather Tam3, Joyce Kullman4, Amanda Eudy5, Renee Borchin6, Cristina Burroughs6, Megan Clowse7 and Peter Merkel2, 1Duke University School of Medicine, Durham, NC, 2University of Pennsylvania, Philadelphia, PA, 3Vasculitis Patient Powered Research Network, Stanford, CA, 4Vasculitis Foundation, Kansas City, MO, 5Duke University, Raleigh, NC, 6University of South Florida, Tampa, FL, 7Duke University, Chapel Hill, NC

    Background/Purpose: There are limited data on the reproductive health and experiences of women with vasculitis. This study engaged women with vasculitis to understand their perspectives…
  • Abstract Number: 0704 • ACR Convergence 2023

    Clinical Characteristics and Outcomes in Patients Found to Have Clinically Isolated Aortitis After Aortic Aneurysm Repair: A Single-Center Experience

    Ora Gewurz-Singer1, Julia Ford2, Thu Thu Aung2 and Lauren Humphrey-Stark2, 1University of Michigan, Huntington Woods, MI, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: Clinically isolated aortitis (CIA), or aortitis in the absence of identifiable systemic vasculitis, is typically discovered histopathologically after aortic aneurysm repair. The approach to…
  • Abstract Number: 1040 • ACR Convergence 2023

    Impact of Ultrasound Limitation to Assess Aortitis in Patients with Giant Cell Arteritis: Comparative Study with FDG-PET/CT

    Juan Molina-Collada1, Isabel Castrejon2, Irene Monjo3, Elisa Fernandez-Fernandez4, Gabriela Torres5, JULIA MARTINEZ BARRIO6, Jose María Alvaro-Gracias7 and Eugenio De Miguel5, 1Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Hospital Universitario Gregorio Marañón, Madrid, Spain, 3University Hospital La Paz, Madrid, Spain, 4La Paz University Hospital, Madrid, Spain, 5Hospital Universitario La Paz, Madrid, Spain, 6Rheumatology, Gregorio Marañon University Hospital, Madrid, Spain, 7Hospital General Universitario Gregorio Marañon, Madrid, Spain

    Background/Purpose: Aortitis is a serious potential complication of patients with giant cell arteritis (GCA) and may lead to dilation, aneurysms or dissection. Since ultrasound (US)…
  • Abstract Number: 1556 • ACR Convergence 2023

    Abdominal Surgical Interventions Among Patients with Gastrointestinal Involvement of Behçet Syndrome

    Sinem Nihal Esatoglu1, Sabriye Guner1, Sevim Guler2, Gulen Hatemi1, Nuray Kepil3, Yusuf Ziya Erzin4, Aykut Ferhat Celik4 and Ibrahim Hatemi4, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul, Turkey, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Pathology, Istanbul, Turkey, 4Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Gastroenterology, Istanbul, Turkey

    Background/Purpose: Gastrointestinal involvement of Behçet's syndrome (GIBS) may require surgery in up to one third of the patients. We aimed to investigate the clinical characteristics,…
  • Abstract Number: 1882 • ACR Convergence 2023

    Imaging in Diagnosis, Monitoring and Outcome Prediction of Large Vessel Vasculitis: A Systematic Literature Review Informing the 2023 Update of the EULAR Recommendations

    Philipp Bosch1, Milena Bond2, Christian Dejaco3, Cristina Ponte4, Sarah Mackie5, Louise Falzon6, Wolfgang Schmidt7 and Sofia Ramiro8, 1Medical University of Graz, Graz, Austria, 2Azienda sanitaria dell'Alto Adige, Merano, Italy, 3Department of Rheumatology, Medical University Graz, Graz, Austria; Department of Rheumatology, Hospital of Bruneck (ASAA-SABES), Teaching Hospital of the Paracelsius Medical University, Brunico, Italy, 4Department of Rheumatology, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 6University of Sheffield, Sheffield, United Kingdom, 7Immanuel Krankenhaus Berlin, Berlin, Germany, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Since the development of the EULAR recommendations for the use of imaging in large vessel vasculitis (LVV) in 2017, new data has emerged in…
  • Abstract Number: 2400 • ACR Convergence 2023

    Applanation Tonometry of the Temporal Arteries in Participants with Suspected Giant Cell Arteritis: A Proof of Concept

    Jean-Paul Makhzoum1, Stephanie Ducharme-Benard2, Samer Hussein2, Rosalie-Selene Meunier2, Carolyn Ross3, Alik Chamlian4, Jonathan Ducharme5, Leia Chamlian4, Alae Dhahbi4, Christian Pagnoux6 and Remi Goupil7, 1Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, Canadian Network for Research on Vasculitides, Montreal, QC, Canada, 2Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada, 3Vasculitis Clinic, Canadian Network for Research on Vasculitides, Hopital du Sacre-Coeur de Montreal, Montreal, QC, Canada, 4Laval University, Montreal, QC, Canada, 5University of Sherbrooke, Montreal, QC, Canada, 6Mount Sinai Hospital, Toronto, ON, Canada, 7Hopital du Sacre-Coeur de Montreal, University of Montreal, Montreal, QC, Canada

    Background/Purpose: Applanation tonometry (ATn) is a non-invasive, point-of-care tool used to capture arterial pressure waveforms. It can measure arterial pulse wave velocity (PWV), a marker…
  • Abstract Number: 2423 • ACR Convergence 2023

    Concordance Between the 1990 ACR Classification Criteria and the New 2022 ACR/EULAR 2022 Criteria in Giant Cell Arteritis

    Julio Sanchez Martin1, Julia Medina Valle1, Javier Loricera1, Maria Fe Garcia Reija1 and Ricardo Blanco2, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Classification criteria for vasculitis, including giant cell arteritis (GCA) are under constant revision. In 2022, the American College of Rheumatology (ACR)/European League Against Rheumatism…
  • Abstract Number: 0675 • ACR Convergence 2023

    Investigating the Impact of anti-IL5 Therapy in the Management of Relapsing and Refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA); A Three Year Longitudinal Perspective and Beyond

    allyson egan1, Pasupathy Sivasothy2 and David Jayne3, 1Trinity Health Kidney Centre, Tallaght University Hospital, Ireland, Dublin, Ireland, 2Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, United Kingdom, 3University of Cambridge, Cambridge, United Kingdom

    Background/Purpose: In the randomized, placebo-controlled MIRRA trial for relapsing and refractory eosinophilic granulomatosis with polyangiitis (EGPA), adjuvant therapy with 300mg anti-IL5 mAB Mepolizumab [MEPO] for…
  • Abstract Number: 0705 • ACR Convergence 2023

    Sleep Disturbances in Patients with Vasculitis: Results of the Vasculitis Patient-Powered Research Network Sleep Study (SleepVasc)

    Misa Tanaka1, Saverio Stranges1, Kathy Speechley1, Osvaldo Espin Garcia1, Molly Mason2, Renee Borchin3, Cristina Burroughs3, Christine Yeung4, Indira Gurubhagavatula4, Christian Pagnoux5, Peter Merkel4 and Lillian Barra1, 1Western University, London, ON, Canada, 2Vasculitis Patient Powered Research Network, Philadelphia, PA, 3University of South Florida, Tampa, FL, 4University of Pennsylvania, Philadelphia, PA, 5Mount Sinai Hospital, Toronto, ON, Canada

    Background/Purpose: Sleep deprivation and sleep disorders can impair health-related quality of life and increase the risk of chronic diseases, such as cardiovascular disease, and mental…
  • Abstract Number: 1061 • ACR Convergence 2023

    Vasculitis as an Immune-Related Adverse Event: Unraveling the Complexities at the Intersection of Immunology and Vascular Pathology

    Chani-mi Lee1, Margaret Wang2, Aarthi Rajkumar1, Cassandra Calabrese3 and Leonard Calabrese3, 1University Hospital, Cleveland, OH, 2Case Western Reserve University, Cleveland, OH, 3Cleveland Clinic / Department of Rheumatic and Immunologic Diseases, Cleveland, OH

    Background/Purpose: Vasculitis as an immune-related adverse event (irAE) from checkpoint inhibitor therapy (ICI) to treat cancer is a rare clinical event, and little is known…
  • Abstract Number: 1558 • ACR Convergence 2023

    Development of Posterior Uveitis in Behçet’s Syndrome Patients with Vitreous Cells Without Any Other Posterior Involvement

    Didar Ucar1, Basak Ecem Bircan2, Nigar Rustamli2, Bilge Batu Oto1, Vedat Hamuryudan3, Sinem Nihal Esatoglu3 and Gulen Hatemi3, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Ophthalmology, Istanbul, Turkey, 2Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Istanbul, Turkey, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

    Background/Purpose: A considerable number of patients with Behçet's syndrome (BS) have vitreous cells (VC) on slit lamp examination at the time of diagnosis. However, the…
  • Abstract Number: 1889 • ACR Convergence 2023

    Utility of a Diagnostic Algorithm in the Assessment of Large Vessel Vasculitis

    HUGO AVALOS BOGADO1, GUSTAVO AÑEZ STURCHIO2, Ernesto Trallero-Araguas3, Esther Espartal López4, sebastián Sandoval Moreno1, daniela Ulloa Navas5 and Juan José De Agustín De Oro2, 1Rheumatology Department Vall d'Hebrón University Hospital, Barcelona, Spain, 2Vall d'Hebron University Hospital, Barcelona, Spain, 3Systemic Autoimmune Disease Unit, Vall d’Hebron Institute of Research, Barcelona, Spain, 4Vall Hebron University Hospital, Rheumatology Department, Barcelona, Spain, 5Rheumatology Department, Vall Hebron University Hospital, Barcelona, Spain

    Background/Purpose: Giant cell arteritis (GCA) is the most prevalent type of primary systemic vasculitis among individuals aged 50 and above. Imaging techniques such as ultrasound…
  • Abstract Number: 2401 • ACR Convergence 2023

    A Study Defining the Optimal Sonographic Parameters for Intima-Media Thickness in Diagnosing Giant Cell Arteritis

    Colm Kirby1, Sharon Cowley2, Rachael Flood1, Ronan Mullan1, Grainne Murphy3 and David Kane4, 1Tallaght University Hospital, Dublin, Ireland, 2Tallaght University Hospital, Dublin, Dublin, Ireland, 3Cork University Hospital, Cork, Ireland, 4Tallaght University Hospital & Trinity College Dublin, Dublin, Ireland

    Background/Purpose: In recent years, Temporal Artery US (TAUS) incorporating Axillary Artery US (AAUS) has become a reliable alternative to biopsy for diagnosing GCA but studies…
  • Abstract Number: 2425 • ACR Convergence 2023

    Pregnancy Outcomes Among Patients with Vasculitis Using Administrative Claims Data

    Amadeia Rector1, Julia Simard2, Gary Shaw3 and Audra Horomanski4, 1Stanford University, San Francisco, CA, 2Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, 3Stanford University, Stanford, CA, 4Stanford University, Palo Alto, CA

    Background/Purpose: Systemic vasculitides are rare, heterogeneous, inflammatory disorders associated with high morbidity and mortality. Recent management and therapeutic advances have improved life expectancy and reproductive…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 35
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology